1-benzyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 500mg

rel-(1R,2R,4S)-2-Bromobicyclo[2.2.1]heptane, 97%, 2.5g

9,10-Diphenylanthracene-2-boronic Acid (contains varying amounts of Anhydride)1g

5-Aminopyrazine-2-carbaldehyde, 96%, 1g

tert-Butyl 2-azaspiro[3.3]heptan-6-ylcarbamate, 97%, 500mg

4-(chloromethyl)-7-hydroxy-8-methyl-2H-chromen-2-one, 95.0%, 2.5g

6-Iodohex-1-yne, 95.0%, 5g

ALOGLIPTIN, 95.0%, 1g

Long working distance plan phase 40x/0.65 IOS objective, working distance 2.74 mm

ETHYL 2-(PYRIDIN-4-YL)PYRIMIDINE-5-CARBOXYLATE, 95%, 250mg

2,5-DIMETHYL-4-IODOPHENOL, 95.0%, 25g

3-Phenylcyclopentanone, 95.0%, 250mg

(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-D-glucitol, 98%, 50mg